Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 4”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Not applicableWithdrawnNCT04100889
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+20 more
ProgenaBiome
Large-scale testing (Phase 3)Active Not RecruitingNCT06304883
What this trial is testing

Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

Who this might be right for
Early Alzheimer's Disease
Alzheon Inc. 163
Early research (Phase 1)Study completedNCT00901498
What this trial is testing

Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseHealthy
Bristol-Myers Squibb 36
Testing effectiveness (Phase 2)Ended earlyNCT00602680
What this trial is testing

Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sanofi 1
Testing effectiveness (Phase 2)Ended earlyNCT01626391
What this trial is testing

Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TauRx Therapeutics Ltd 9
Early research (Phase 1)Study completedNCT05532358
What this trial is testing

A Drug-Drug Interaction Study to Assess the CYP1A2 and CYP3A4 Interaction Potential of TEV-56286 (anle138b)

Who this might be right for
Healthy Volunteers
MODAG GmbH 54
Early research (Phase 1)Study completedNCT04685265
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of anle138b in Parkinson's Disease

Who this might be right for
Parkinson Disease
MODAG GmbH 70
Early research (Phase 1)Looking for participantsNCT06372821
What this trial is testing

A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK

Who this might be right for
Alzheimer DiseaseAutosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder)Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder)+1 more
University College, London 10
Large-scale testing (Phase 3)Ended earlyNCT00667810
What this trial is testing

Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients

Who this might be right for
Alzheimer Disease
Pfizer 901
Large-scale testing (Phase 3)Looking for participantsNCT06702124
What this trial is testing

Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
I.R.C.C.S. Fondazione Santa Lucia 348
Testing effectiveness (Phase 2)Study completedNCT00040443
What this trial is testing

Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment.

Who this might be right for
Mild Cognitive Impairment
RespireRx 175
Not applicableLooking for participantsNCT06733714
What this trial is testing

Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults

Who this might be right for
Cognitive DysfunctionAlzheimer DiseaseMild Cognitive Impairment+8 more
Universidade Federal do Rio de Janeiro 40
Large-scale testing (Phase 3)Ended earlyNCT00676143
What this trial is testing

Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients

Who this might be right for
Alzheimer Disease
Pfizer 1,100
Large-scale testing (Phase 3)Ended earlyNCT00998764
What this trial is testing

A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients

Who this might be right for
Alzheimer Disease
Pfizer 494
Testing effectiveness (Phase 2)Ended earlyNCT00582855
What this trial is testing

Effect of AQW051 in Patients With Memory Impairment

Who this might be right for
Mild Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
Novartis Pharmaceuticals 54
Early research (Phase 1)Study completedNCT01979406
What this trial is testing

Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Vaccines

Who this might be right for
Anthrax Infection
Emergent BioSolutions 120
Post-approval studies (Phase 4)Not Yet RecruitingNCT06911944
What this trial is testing

Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

Who this might be right for
Down Syndrome (DS)Down Syndrome (Trisomy 21)Alzheimer Disease+1 more
Michael Rafii, MD, PhD 60
Early research (Phase 1)Study completedNCT01443936
What this trial is testing

Experimental AD4-H5-VTN Vaccine in Healthy Volunteers

Who this might be right for
H5N1 Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 96
Early research (Phase 1)Study completedNCT01978548
What this trial is testing

Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen Research & Development, LLC 45
Early research (Phase 1)Ended earlyNCT01137799
What this trial is testing

The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients

Who this might be right for
SchizophreniaAlzheimer's DiseaseCognition Disorders
Janssen Pharmaceutica N.V., Belgium 47
Load More Results